Literature DB >> 19004824

Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.

Flavia Pichiorri1, Hiroshi Okumura, Tatsuya Nakamura, Preston N Garrison, Pierluigi Gasparini, Sung-Suk Suh, Teresa Druck, Kelly A McCorkell, Larry D Barnes, Carlo M Croce, Kay Huebner.   

Abstract

We have previously shown that Fhit tumor suppressor protein interacts with Hsp60 chaperone machinery and ferredoxin reductase (Fdxr) protein. Fhit-effector interactions are associated with a Fhit-dependent increase in Fdxr stability, followed by generation of reactive oxygen species and apoptosis induction under conditions of oxidative stress. To define Fhit structural features that affect interactions, downstream signaling, and biological outcomes, we used cancer cells expressing Fhit mutants with amino acid substitutions that alter enzymatic activity, enzyme substrate binding, or phosphorylation at tyrosine 114. Gastric cancer cell clones stably expressing mutants that do not bind substrate or cannot be phosphorylated showed decreased binding to Hsp60 and Fdxr and reduced mitochondrial localization. Expression of Fhit or mutants that bind interactor proteins results in oxidative damage and accumulation of cells in G(2)/M or sub-G(1) fractions after peroxide treatment; noninteracting mutants are defective in these biological effects. Gastric cancer clones expressing noncomplexing Fhit mutants show reduction of Fhit tumor suppressor activity, confirming that substrate binding, interaction with heat shock proteins, mitochondrial localization, and interaction with Fdxr are important for Fhit tumor suppressor function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004824      PMCID: PMC2613607          DOI: 10.1074/jbc.M806638200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Location of dinucleoside triphosphatase in the matrix space of rat liver mitochondria.

Authors:  D Bernet; R M Pinto; A Sillero; J C Cameselle
Journal:  FEBS Lett       Date:  1991-06-03       Impact factor: 4.124

2.  Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

Authors:  H Ishii; K R Dumon; A Vecchione; F Trapasso; K Mimori; H Alder; M Mori; G Sozzi; R Baffa; K Huebner; C M Croce
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

3.  The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.

Authors:  Gang Liu; Xinbin Chen
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

Review 4.  FRA3B and other common fragile sites: the weakest links.

Authors:  K Huebner; C M Croce
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

5.  Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Authors:  Luca Roz; Marcella Gramegna; Hideshi Ishii; Carlo M Croce; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.

Authors:  Francesco Trapasso; Agnieszka Krakowiak; Rossano Cesari; Jeffrey Arkles; Sai Yendamuri; Hideshi Ishii; Andrea Vecchione; Tamotsu Kuroki; Pawel Bieganowski; Helen C Pace; Kay Huebner; Carlo M Croce; Charles Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

7.  Fhit is a physiological target of the protein kinase Src.

Authors:  Yuri Pekarsky; Preston N Garrison; Alexey Palamarchuk; Nicola Zanesi; Rami I Aqeilan; Kay Huebner; Larry D Barnes; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

8.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

9.  Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells.

Authors:  Francesco Trapasso; Flavia Pichiorri; Marco Gaspari; Tiziana Palumbo; Rami I Aqeilan; Eugenio Gaudio; Hiroshi Okumura; Rodolfo Iuliano; Giampiero Di Leva; Muller Fabbri; David E Birk; Cinzia Raso; Kari Green-Church; Luigi G Spagnoli; Salvatore Venuta; Kay Huebner; Carlo M Croce
Journal:  J Biol Chem       Date:  2008-03-03       Impact factor: 5.157

10.  Cancer and the FRA3B/FHIT fragile locus: it's a HIT.

Authors:  K Huebner; C M Croce
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more
  17 in total

Review 1.  Hits, Fhits and Nits: beyond enzymatic function.

Authors:  Kay Huebner; Joshua C Saldivar; Jin Sun; Hidetaka Shibata; Teresa Druck
Journal:  Adv Enzyme Regul       Date:  2010-10-28

2.  Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis.

Authors:  He-Ling Wang; Ping-Yi Zhou; Peng Liu; Yu Zhang
Journal:  Tumour Biol       Date:  2014-04-12

3.  Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Authors:  Daniel L Kiss; Catherine E Waters; Iman M Ouda; Joshua C Saldivar; Jenna R Karras; Zaynab A Amin; Seham Mahrous; Teresa Druck; Ralf A Bundschuh; Daniel R Schoenberg; Kay Huebner
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-14       Impact factor: 4.490

4.  A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.

Authors:  Jennifer A Boylston; Charles Brenner
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Characterization of the role of Fhit in suppression of DNA damage.

Authors:  Joshua C Saldivar; Jessica Bene; Seyed Ali Hosseini; Satoshi Miuma; Susan Horton; Nyla A Heerema; Kay Huebner
Journal:  Adv Biol Regul       Date:  2012-10-11

6.  Nit1 and Fhit tumor suppressor activities are additive.

Authors:  Jin Sun; Hiroshi Okumura; Martha Yearsley; Wendy Frankel; Louise Y Fong; Teresa Druck; Kay Huebner
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

Review 7.  The FHIT gene product: tumor suppressor and genome "caretaker".

Authors:  Catherine E Waters; Joshua C Saldivar; Seyed Ali Hosseini; Kay Huebner
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

8.  Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR.

Authors:  Aparna Bhaduri; Alexander Ungewickell; Lisa D Boxer; Vanessa Lopez-Pajares; Brian J Zarnegar; Paul A Khavari
Journal:  Dev Cell       Date:  2015-11-23       Impact factor: 12.270

Review 9.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

10.  Initiation of genome instability and preneoplastic processes through loss of Fhit expression.

Authors:  Joshua C Saldivar; Satoshi Miuma; Jessica Bene; Seyed Ali Hosseini; Hidetaka Shibata; Jin Sun; Linda J Wheeler; Christopher K Mathews; Kay Huebner
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.